MOLOGEN AG / Key word(s): Capital Increase
10.07.2012 08:25
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
MOLOGEN AG capital increase: Proceeds of 22 million EUR
As part of the current capital increase MOLOGEN AG has achieved gross
proceeds of 22 million EUR. Overall, 2,589,819 new shares have been placed
at an issue price of 8.50 EUR. Existing investors contributed in a
significant amount to the capital increase. In addition, subscriptions for
shares by national and international institutional investors supplemented
the order book. The funds are to be primarily used for further expansion of
the product pipeline.
The Management and Supervisory Board of the company will file the
implementation of the capital increase for entry in the German Commercial
Register immediately. The delivery of the new shares is expected to take
place one banking day after the admission of the new shares to trading on
the Regulated Market of the Frankfurt Stock Exchange with additional
post-admission obligations (Prime Standard), i.e. on July 16, 2012.
The quirin bank AG was responsible for overseeing the capital increase.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
'With the proceeds raised, we are able to further expand our product
pipeline as planned. In addition, the financial basis of MOLOGEN AG has
been strengthened substantially thus improving our position in the
negotiation process for the out-licensing of MGN1703 considerably', said
Dr. Matthias Schroff, Chief Executive Officer of MOLOGEN AG.
10.07.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: MOLOGEN AG
FabeckstraÃe 30
14195 Berlin
Germany
Phone: 030 / 841788-0
Fax: 030 / 841788-50
E-mail: info@mologen.com
Internet: www.mologen.com
ISIN: DE0006637200
WKN: 663720
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: MOLOGEN AG capital increase: Proceeds of 22 million EUR
| Source: EQS Group AG